PeptiMed, Inc. logo

PeptiMed, Inc.

PeptiMed, Inc., a biotechnology corporation, develops a small interfering RNA (siRNA) therapeutic drug that targets the EVI1 gene called siEVI1 for treatment of advanced breast, prostate, lung, colon, ovarian, and skin cancers.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://peptimed.com
Founded2012
Disease Focus
Development Stage
STOCK CODENon Listed
Address
921 Walsh Road Suite 208, WI, 53714
Madison
United States
Email
Contact Number
+1 608-335-4620

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/peptimed” connections=”true” suffix=””]